Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight photodynamic therapy for Bowen's disease
RBR-38zsszRecruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- May 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of methyl aminolevulinate, sponsored by Hospital de Clínicas de Porto Alegre. Started May 2016; status: recruiting.
02
Drugs
methyl aminolevulinate
Beyond the preview
Go deeper on RBR-38zssz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-38zssz.